Atlanta, GA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)Rheumatology Research Foundation, founded in 1985, is a mid-sized nonprofit in the Medical Research sector that reported $19.8M in total revenue in fiscal year 2024. Revenue surged 42% from the prior year, signaling strong growth momentum. Expenses of $17.1M left a modest 14% surplus.
SUPPORT RESEARCH & TRAINING THAT ADVANCES THE PREVENTION, TREATMENT AND CURE OF RHEUMATIC DISEASES.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $19,785,814 | $13,965,881 | +0.4% |
| Expenses | $17,070,676 | $17,398,192 | 0.0% |
| Net Income | $2,715,138 | $-3,432,311 | -1.8% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| Anne Bass MD | Treasurer (2023-2025) | 14.0 |
Officer
Director
|
$0 | $0 | $47,300 |
| Bryce Binstadt MD PhD | Foundation Vice President (2023-2025) | 14.0 |
Officer
Director
|
$0 | $0 | $3,434 |
| Liana Fraenkel MD MPH | Foundation President (2023-2025) | 14.0 |
Officer
Director
|
$0 | $0 | $69,000 |
| Alexis Ogdie MD | Member at Large (2024-2027) | 2.0 |
Director
|
$0 | $0 | $2,500 |
| Alfred Kim MD PhD | Chair, Impact Advisory Council (2023-2026) | 2.0 |
Director
|
$0 | $0 | $1,000 |
| Angus Worthing MD | Secretary (2024-2026) | 2.0 |
Director
|
$0 | $0 | $0 |
| Anisha Dua MD | Chair, ACR Committee on Training (2024-2027) | 2.0 |
Director
|
$0 | $0 | $0 |
| Carol Young MD | Member at Large (2022-2025) | 2.0 |
Director
|
$0 | $0 | $0 |
| Charles Saia | Member at Large (2024-2027) | 2.0 |
Director
|
$0 | $0 | $0 |
| Corinne Karp MAEd | Member at Large (2022-2025) | 2.0 |
Director
|
$0 | $0 | $0 |
| Edward Behrens MD | Chair, Scientific Advisory Council (2023-2026) | 2.0 |
Director
|
$0 | $0 | $2,956 |
| Firas Kassab MD | Member at Large (2022-2025) | 2.0 |
Director
|
$0 | $0 | $0 |
| Jay Norman | Member at Large (2024-2027) | 2.0 |
Director
|
$0 | $0 | $0 |
| Jody Hargrove MD | Chair, Development Advisory Council (2022-2025) | 2.0 |
Director
|
$0 | $0 | $0 |
| Linda Hiraki MD MS ScD | ACR Research Representative (2023-2026) | 2.0 |
Director
|
$0 | $0 | $0 |
| M Elaine Husni MD | Member at Large (2023-2026) | 2.0 |
Director
|
$0 | $0 | $0 |
| Rina Joshi DO | Fellow-In-Training Representative (2024-2025) | 2.0 |
Director
|
$0 | $0 | $0 |
| Ryan DeMassi MD | Corporate Roundtable Representative - 2023-2025 | 2.0 |
Director
|
$0 | $0 | $0 |
| Susan Bartlett PhD | ARP Representative (2024-2027) | 2.0 |
Director
|
$0 | $0 | $2,385 |
| Ted Mikuls MD MSHP | Member at Large (2023-2026) | 2.0 |
Director
|
$0 | $0 | $0 |
| Colleen Merkel | VP, Operations and Finance | 1.0 |
Key Emp
|
$0 | $49,300 | $295,381 |
| Eryn Marchiolo | VP, Mission | 1.0 |
Key Emp
|
$0 | $30,479 | $200,878 |
| Mona Bhavsar | Sr. Director, Controller | 1.0 |
Key Emp
|
$0 | $36,237 | $187,061 |
| Paula Reed | VP, Philanthropy | 1.0 |
Key Emp
|
$0 | $31,255 | $208,451 |
| Rachel Myslinski | Executive Director | 1.0 |
Key Emp
|
$0 | $45,590 | $274,223 |
| Benjamin Walkuski | Director, Individual Engagement & Philanthropy | 1.0 |
Highest
|
$0 | $25,615 | $146,540 |
| Colette Novak | Director, Data Strategy | 1.0 |
Highest
|
$0 | $31,830 | $133,410 |
| Kay Butts-Pruett | Sr. Director, Philanthropy | 1.0 |
Highest
|
$0 | $26,649 | $162,348 |
| Lauren Adalfio | Senior Manager, Finance | 1.0 |
Highest
|
$0 | $33,836 | $158,385 |
| Michael Greer | Director, Philanthropy Officer | 1.0 |
Highest
|
$0 | $28,219 | $131,743 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | $19,785,814 | $17,070,676 | $76,434,619 | $2,715,138 |
| 2024 | $13,965,881 | $17,398,192 | $70,729,610 | $-3,432,311 |
| 2023 | $13,039,465 | $17,402,769 | $70,496,543 | $-4,363,304 |
| 2022 | $7,906,919 | $16,411,503 | $70,647,398 | $-8,504,584 |
| 2021 | $23,684,495 | $15,965,678 | $86,854,419 | $7,718,817 |
| 2020 | $10,312,979 | $13,475,852 | $70,977,667 | $-3,162,873 |
| 2019 | $13,527,750 | $12,713,963 | $73,274,185 | $813,787 |
| 2018 | $29,567,657 | $13,523,272 | $71,590,041 | $16,044,385 |
Compare Rheumatology Research Foundation with other nonprofits in Georgia and across the country.